E-mail Updates- Home
- Slides
- Home
- Tools and Resources
- Research Summaries for Consumers, Clinicians, and Policymakers
- Search for Research Summaries, Reviews, and Reports
- Research Available for Comment
- Submit a Suggestion for Research
- Submit Scientific Information Packets
- Comparative Effectiveness Research Grant and ARRA Awards
- News and Announcements
- What Is Comparative Effectiveness Research
- Who Is Involved in the Effective Health Care Program
- What Is the Effective Health Care Program
Slides
Slides: 1–12 of 27
Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Testing for the Evaluation of Musculoskeletal Complaints in Pediatric Populations
Background: Using Serological Tests To Diagnose Musculoskeletal Pain
Clinical Questions Addressed by the CER (1 of 3)
Keywords: key questions | clinical questions | prevalence | incidence | natural history | musculoskeletal pain | children | adolescents
Clinical Questions Addressed by the CER (2 of 3)
Keywords: key questions | clinical questions | clinical diagnosis | musculoskeletal pain | children | adolescents | antinuclear antibody | cyclic-citrullinated peptide | rheumatoid factor | juvenile idiopathic arthritis | pediatric systemic lupus erythematosus | test performance | test sensitivity | test specificity | positive predictive value | negative predictive value
Clinical Questions Addressed by the CER (3 of 3)
Keywords: key questions | clinical questions | musculoskeletal pain | juvenile idiopathic arthritis | pediatric systemic lupus erythematosus | children | adolescents | age | sex | race | ethnicity | comorbidity | recent infection | antinuclear antibody | cyclic-citrullinated peptide | rheumatoid factor | test performance | test sensitivity | test specificity | positive predictive value | negative predictive value | referral decisions | clinical management | clinical uncertainty
Report Findings: Prevalence of Musculoskeletal Pain Among Healthy Children
Keywords: musculoskeletal pain | nontraumatic pain | prevalence | healthy children | healthy adolescents | age | sex | headache | abdominal pain | recurrence predictors
Conclusions (1 of 2)
Keywords: adolescents | age | children | clinical assessment | juvenile idiopathic arthritis | noninflammatory pain | prevalence | sex | test sensitivity | test specificity | musculoskeletal pain
What To Discuss With Your Patients
Intermediate End Points and Health Outcomes in rhGH-Treated Patients With CF (2)
First- and Second-Generation Antipsychotics for Children and Young Adults
Introduction to Antipsychotics in Pediatric Use (3 of 4)
Antipsychotics Approved for Pediatric Use: Second-Generation Antipsychotics
Your slide tray is being processed.
